These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21350111)

  • 21. Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study.
    Kuo TH; Lin WH; Chao JY; Wu AB; Tseng CC; Chang YT; Liou HH; Wang MC
    BMC Nephrol; 2019 Jul; 20(1):266. PubMed ID: 31315601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.
    Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
    Clin Nutr; 2020 Aug; 39(8):2435-2441. PubMed ID: 31732290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
    Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting.
    Yuan J; Watanabe M; Suliman M; Qureshi AR; Axelsson J; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Feb; 30(2):274-82. PubMed ID: 23975839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation and nutritional status assessment by malnutrition inflammation score and its outcome in pre-dialysis chronic kidney disease patients.
    Jagadeswaran D; Indhumathi E; Hemamalini AJ; Sivakumar V; Soundararajan P; Jayakumar M
    Clin Nutr; 2019 Feb; 38(1):341-347. PubMed ID: 29398341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: results from the KNHANES 2008-2011.
    Lee YH; Kim JE; Roh YH; Choi HR; Rhee Y; Kang DR; Lim SK
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3879-88. PubMed ID: 24878040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between uric acid and bone mineral density in the intermediate stage of CKD 1-3.
    Yang R; Ding N; Qin J; Peng H
    BMC Nephrol; 2024 Jul; 25(1):219. PubMed ID: 38982346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study.
    Guan Y; Lv F; Meng Y; Ma D; Xu X; Song Y; Wang O; Jiang Y; Xia W; Xing X; Zhang J; Li M
    Osteoporos Int; 2017 Aug; 28(8):2383-2390. PubMed ID: 28439619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Associations Between Body Cell Mass and Nutritional and Inflammatory Markers in Patients With Chronic Kidney Disease and in Subjects Without Kidney Disease.
    Rymarz A; Bartoszewicz Z; Szamotulska K; Niemczyk S
    J Ren Nutr; 2016 Mar; 26(2):87-92. PubMed ID: 26559600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.
    Desjardins L; Liabeuf S; Renard C; Lenglet A; Lemke HD; Choukroun G; Drueke TB; Massy ZA;
    Osteoporos Int; 2012 Jul; 23(7):2017-25. PubMed ID: 22109743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and associated factors of protein- energy wasting among patients with chronic kidney disease at Mulago hospital, Kampala-Uganda: a cross-sectional study.
    Namuyimbwa L; Atuheire C; Okullo J; Kalyesubula R
    BMC Nephrol; 2018 Jun; 19(1):139. PubMed ID: 29902980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Plasma Concentration of Klotho Protein, Osteocalcin, Leptin, Adiponectin, and Bone Mineral Density in Patients with Chronic Kidney Disease.
    Marchelek-Mysliwiec M; Wisniewska M; Nowosiad-Magda M; Safranow K; Kwiatkowska E; Banach B; Dołegowska B; Dołegowska K; Stepniewska J; Domanski L; Pawlik A; Ciechanowski K
    Horm Metab Res; 2018 Nov; 50(11):816-821. PubMed ID: 30396210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
    Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
    Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between mild-to-moderate chronic kidney disease and decreased bone mineral density in Chinese adult population.
    Kong X; Tang L; Ma X; Liu W; Wang Z; Cui M; Xu D
    Int Urol Nephrol; 2015 Sep; 47(9):1547-53. PubMed ID: 26265108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease.
    Jamal S; Cheung AM; West S; Lok C
    Osteoporos Int; 2012 Dec; 23(12):2805-13. PubMed ID: 22297732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.
    Yun HJ; Ryoo SR; Kim JE; Choi YJ; Park I; Shin GT; Kim H; Jeong JC
    BMC Nephrol; 2020 Jul; 21(1):299. PubMed ID: 32711466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers of Bone Turnover Identify Subsets of Chronic Kidney Disease Patients at Higher Risk for Fracture.
    Hughes-Austin JM; Katz R; Semba RD; Kritchevsky SB; Bauer DC; Sarnak MJ; Ginsberg C; Shlipak MG; Lima F; Malluche HH; Ix JH
    J Clin Endocrinol Metab; 2020 Aug; 105(8):e2903-11. PubMed ID: 32474604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.
    Bojesen A; Birkebæk N; Kristensen K; Heickendorff L; Mosekilde L; Christiansen JS; Gravholt CH
    Osteoporos Int; 2011 May; 22(5):1441-50. PubMed ID: 20658127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.